APA (7th ed.) Citation

Zheng, C., Lin, M., Chen, Y., Xu, H., Yan, L., & Dai, H. (2021). Effects of sodium‐glucose cotransporter type 2 inhibitors on cardiovascular, renal, and safety outcomes in patients with cardiovascular disease: A meta‐analysis of randomized controlled trials. Cardiovascular Diabetology, 20(1), 1. https://doi.org/10.1186/s12933-021-01272-z

Chicago Style (17th ed.) Citation

Zheng, Caiyun, Meimei Lin, Yan Chen, Haiting Xu, Lingqun Yan, and Hengfen Dai. "Effects of Sodium‐glucose Cotransporter Type 2 Inhibitors on Cardiovascular, Renal, and Safety Outcomes in Patients with Cardiovascular Disease: A Meta‐analysis of Randomized Controlled Trials." Cardiovascular Diabetology 20, no. 1 (2021): 1. https://doi.org/10.1186/s12933-021-01272-z.

MLA (9th ed.) Citation

Zheng, Caiyun, et al. "Effects of Sodium‐glucose Cotransporter Type 2 Inhibitors on Cardiovascular, Renal, and Safety Outcomes in Patients with Cardiovascular Disease: A Meta‐analysis of Randomized Controlled Trials." Cardiovascular Diabetology, vol. 20, no. 1, 2021, p. 1, https://doi.org/10.1186/s12933-021-01272-z.